Stockreport

Sarepta Elevidys accelerated approval criticized by ICER exec [Seeking Alpha]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF of Sarepta Therapeutics' ( NASDAQ: SRPT ) Duchenne muscular dystrophy treatment Elevidys (delandistrogene moxeparvovec) as an example. In a viewpoint for JAMA , Instit [Read more]